Summary
Overview
Work History
Education
Skills
Websites
Accomplishments
Leadershipandstrategicinitiatives
Timeline
Generic
JENNIFER VAN UFFELEN

JENNIFER VAN UFFELEN

Inland Empire

Summary

REGIONAL SALES LEADERSHIP | STRATEGIC MARKET DEVELOPMENT | TEAM DEVELOPMENT

Results-oriented professional with extensive leadership experience in high-stakes environments. Skilled in strategic planning, operational optimization, and organizational growth. Known for fostering team collaboration and delivering results under changing conditions. Key strengths include strategic vision and stakeholder management.

Overview

19
19
years of professional experience

Work History

Executive Therapeutic Specialist

GILEAD SCIENCES
03.2021 - Current
  • Launched a new rare disease treatment by leading Liver Transplant Center trainings, securing 100% of new patient starts in 2H 2024 within a competitive PBC market
  • Led HCV elimination efforts, establishing partnerships with public health agencies, emergency departments, and major health plans (75% of HCV patient lives), expanding patient access and optimizing treatment pathways
  • Implemented HCV screening and treatment protocols across hospitals, FQHCs, and MAT programs, reducing provider workload, minimizing redundant lab testing, and increasing treatment initiations by 10%+ YOY
  • Developed 5+ new treatment centers annually, expanding the HCV advocacy network, improving provider engagement, and maintaining 70%+ market share

Senior Therapeutic Specialist

GILEAD SCIENCES
03.2018 - 03.2021
  • Increased HCV treatment adoption by 95%+, working with P&T committees to drive therapeutic interchange approvals
  • Strengthened provider engagement, securing 95%+ market share in one of Gilead’s highest-volume territories
  • Recovered 30% market share from non-formulary status, leading targeted market access initiatives

Therapeutic Specialist

GILEAD SCIENCES
04.2015 - 03.2018
  • Exceeded sales targets (119%-131%), driving market growth at three HCV Centers of Excellence
  • Streamlined patient identification & treatment workflows, reducing delays and improving referral efficiency

Executive Territory Manager

SALIX PHARMACEUTICALS
04.2012 - 04.2015
  • Achieved 185% TRX growth in a competitive market by leading high-science in-services and provider education initiatives
  • Launched Solesta (Buy-and-Bill model), training large health systems & private offices on reimbursement strategies

Executive Hospital Account Specialist

NOVARTIS PHARMACEUTICALS
08.2006 - 04.2012
  • Grew Reclast Infusion (+20%) & Exelon Patch (+18%) market share in hospitals & Long-Term Care facilities
  • Led J-Code reimbursement integrations, improving infusion therapy adoption in key hospital systems

Education

B.S. - Communications – Marketing & Advertising

Northern Arizona University
Flagstaff, AZ

Skills

  • Interpersonal skills
  • Operations management
  • Executive support
  • Customer-oriented

Accomplishments

  • Achieved [Result] through effectively helping with [Task].
  • Business Development: - Spearheaded acquisition of two competitor companies.Established and managed partner relationships on a daily basis. Developed new marketing strategy which increased customer base by 23%.

Leadershipandstrategicinitiatives

  • Gilead Leadership Development Program, Top Graduate, 2024
  • Women at Gilead – Global, Designed high-impact engagement events with executive speakers.
  • Founder, Women at Gilead – Kite SoCal Chapter, Built a 175+ member network, securing executive sponsorship.
  • Regional Trainer, 9 years, Mentored & trained new and tenured sales specialists, driving performance acceleration.

Timeline

Executive Therapeutic Specialist

GILEAD SCIENCES
03.2021 - Current

Senior Therapeutic Specialist

GILEAD SCIENCES
03.2018 - 03.2021

Therapeutic Specialist

GILEAD SCIENCES
04.2015 - 03.2018

Executive Territory Manager

SALIX PHARMACEUTICALS
04.2012 - 04.2015

Executive Hospital Account Specialist

NOVARTIS PHARMACEUTICALS
08.2006 - 04.2012

B.S. - Communications – Marketing & Advertising

Northern Arizona University
JENNIFER VAN UFFELEN